Recurrent Adult Diffuse Midline Glioma, H3 K27-Mutant
1 clinical trials · Condition
◉ Watch Recurrent Adult Diffuse Midline Glioma, H3 K27-Mutant
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma (NCT06860594) | National Cancer Institute (NCI) | 2025-07-30 |
Track Recurrent Adult Diffuse Midline Glioma, H3 K27-Mutant automatically
Every clearance here is in the API, with alerts when new ones post.